A
D
RISKY
21
Total CVEs
15
Crit / High
3
Medium
10%
Unpatched
0%
Patched
7.7
Avg CVSS
0
CISA KEV
// Data sourced from NVD · CISA KEV · RHSA · GHSA · Debian · OSV · EPSS · Exploit-DB How we collect data →
// INTEL UPGRADE
Full Company Dossier — Coming Soon
Executive profiles, financial exposure, M&A risk, breach history & supply-chain threat mapping — all in one place.
OSINT FINANCIALS EXEC PROFILES BREACH DB
▸ CVE Trend by Year
▸ Patch Coverage
Patched
0%
Unpatched
10%
Under Review
86%
Pending
5%
✓ 0 patched ✗ 2 unpatched ~ 18 under review ⏳ 1 pending score
▸ Intelligence by Audience
PoC Available
2 / 20 shown
CISA KEV (Exploited)
0
Shodan Dorks
ssl:"aimhubio" port:443
org:"Aimhubio" http.status:200
Top EPSS (Exploitation Probability)
CVE-2024-6396 53.11% exploitation probability
CVE-2024-2195 1.81% exploitation probability
CVE-2024-6851 0.99% exploitation probability
CVE-2024-8769 0.91% exploitation probability
CVE-2024-6829 0.87% exploitation probability
Quick Facts for Reporting
Total CVEs tracked
21
Critical severity
4
Actively exploited (CISA)
0
Unpatched ratio
10%
Avg CVSS score
7.7
Security grade
D (RISKY)
NVD Data Attribution
Source: NIST National Vulnerability Database (NVD) + GitHub Advisory Database.
Data aggregated by Valters IT Hub · valtersit.com
Last updated: 2026-08-03
Security Risk Score (for investors)
LOW
Vuln Volume
GOOD
Patch Responsiveness
LOW
CISA Exposure
⚠ Not financial advice. Past security incidents do not guarantee future stock performance.
▸ Security News Google News

No recent security news found for Aimhubio.

▸ Recent CVEs showing 20 of 21
CVE IDSeverityPatchEPSSDate
CVE-2025-51464 ? N/A UNKNOWN / UNPATCHED 0.60% 2025-07-22
CVE-2025-5321 5.3 MEDIUM UNKNOWN / UNPATCHED 0.59% 2025-05-29
CVE-2024-8101 PoC 7.2 HIGH PATCH UNDER REVIEW 0.23% 2025-03-20
CVE-2024-8769 9.1 CRITICAL PATCH UNDER REVIEW 0.91% 2025-03-20
CVE-2024-12777 5.9 MEDIUM PATCH UNDER REVIEW 0.46% 2025-03-20
CVE-2024-8238 5.9 MEDIUM PATCH UNDER REVIEW 0.75% 2025-03-20
CVE-2025-0189 7.5 HIGH PATCH UNDER REVIEW 0.62% 2025-03-20
CVE-2024-6829 9.1 CRITICAL PATCH UNDER REVIEW 0.87% 2025-03-20
CVE-2024-12778 7.5 HIGH PATCH UNDER REVIEW 0.76% 2025-03-20
CVE-2024-8061 7.5 HIGH PATCH UNDER REVIEW 0.46% 2025-03-20
CVE-2024-6851 7.5 HIGH PATCH UNDER REVIEW 0.99% 2025-03-20
CVE-2024-6483 5.3 MEDIUM PATCH UNDER REVIEW 0.85% 2025-03-20
CVE-2024-10110 7.5 HIGH PATCH UNDER REVIEW 0.61% 2025-03-20
CVE-2024-7760 7.4 HIGH PATCH UNDER REVIEW 0.51% 2025-03-20
CVE-2025-0190 7.5 HIGH PATCH UNDER REVIEW 0.62% 2025-03-20
CVE-2024-8863 5.3 MEDIUM UNKNOWN / UNPATCHED 0.50% 2024-09-14
CVE-2024-6578 7.2 HIGH PATCH UNDER REVIEW 0.28% 2024-07-29
CVE-2024-6396 PoC 9.8 CRITICAL PATCH UNDER REVIEW 53.11% 2024-07-12
CVE-2024-6227 7.5 HIGH PATCH UNDER REVIEW 0.57% 2024-07-08
CVE-2024-2195 9.8 CRITICAL PATCH UNDER REVIEW 1.81% 2024-04-10
View all 21 CVEs for Aimhubio →
▸Intel
Trust ScoreD — RISKY
Max CVSS9.8
Last Updated2026-08-03
▸Company Profile

Aimhubio is a software vendor that provides an open-source experiment tracking and management platform for machine learning, known as Aim. The platform allows data scientists and ML engineers to log, visualize, and compare AI experiments, with a focus on scalability and performance. Its cybersecurity relevance stems from potential vulnerabilities in its web-based UI and API that could expose sensitive model data or enable remote code execution, as reflected in its tracked CVEs.

▸Response Metrics
Est. MTTR ⓘ ~500 days (Critical)
Mean Time To Remediate. Estimates days from CVE disclosure to patch.
Industry avg: ~60d (good) · 100-300d (poor) · 300d+ (critical)
CVE Trend ⓘ ↗ +150% worse
CVE count 2025 vs 2024:  6 → 15 CVEs
Patch Speed ⓘ Poor (>65% open)
10% of CVEs still unpatched.  Excellent: <20% · Good: 20-40% · Avg: 40-65% · Poor: >65%
▸ Financial Risk Estimate
Est. GDPR Low
€640K
Est. GDPR High
€6.4M

Based on 4 critical CVEs, 0 CISA KEV, 100% unpatched. Model: GDPR Art.83 · not legal advice.

▸Actions
⚖ Compare with another vendor
▸Embed Badge
Aimhubio D valtersit.com